• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DLM
Click for more information
0.00% 3.2¢

DOMINION MINERALS LIMITED - Corporate Spotlight

Market Cap $7.227M  ! watchlist Created with Sketch. Add to my watchlist

Dominion Minerals Limited is an Australia-based mineral exploration company. The Company... Dominion Minerals Limited is an Australia-based mineral exploration company. The Company is focused on advancing a calcium limestone project in the heart of Georgia, United States of America. The Company’s 100% owned United States subsidiary, PowerLime, Inc. (PowerLime) holds a 100% interest in the Georgia Lime Project, comprised of an option to purchase 361 acres of private surface and mineral rights in Early County, Georgia. Its Georgia Lime Project consists of high calcium limestone.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
3.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $7.227M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
DLM (ASX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Hastings progressing Yangibana to production with lower costs Hastings Technology Metals Ltd has released its annual report to shareholders, saying that it has reduced capital costs by $56 million
Zenith's sale of Develin Creek delivers $975K cash, with shares up 13% Zenith Minerals Ltd has completed its sale of Develin Creek copper-zinc project in Queensland to QMines Ltd
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
The iron ore comeback: Can it last? The Chinese need our iron ore and we could do with the cash if we are sensible enough to put the stuff on a boat and sell it to them.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.